We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 124 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Anyone follow this one. Worth magazine has labeled ISIP the next Microsoft.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4676Ionis Pharmaceuticals Inc. (IONS) Halted due to pending newssjemmeri-10/5/2018
4675Down over 10% with no news that I have seen. Has anyone seen something that can scots40-7/25/2017
4674Bullish crossover in MACD and Stochastic oscillator. [graphic]hollyhunter-5/29/2017 Warning letter to an investigator in amyloidosis trial.scaram(o)uche-5/10/2017
4672I see NO NEWS out, yet the stock is down 6% on heavy volume. The drop started ascots40-5/10/2017
4671>>I bought a mini position at the close, looking for 30% or so retrace of tuck-4/8/2016
4670Ionis' TTR-rx program had a superficially strange hiccup today. It's rutuck-4/7/2016
4669WESTON, Mass. and CARLSBAD, Calif., Sept. 9, 2013 /PRNewswire/ -- Biogen Idec (Bnigel bates19/9/2013
4668Anyone still interested in ISIS? For example, what should an investor make ofDSMIA-6/8/2013
4667So Aegerion's drug and Isis' kynamro both given a thumbs up by the AC, wtuck-10/18/2012 fellows aren't following ISIS anymore? Nice move since February...temco2-9/4/2012
4665Competitor KaroBio stops development of their lead drug, which was aiming at thetuck-2/14/2012
4664ISIS partners a niche drug early. Not sure how big this market is in dollars. tuck21/4/2012
4663Pfizer is taking Excaliard out, and Isis will get a portion of upfront , milestotuck-11/22/2011
4662Genzyme and Isis Announce Submission of European Marketing Authorization Applicabob zagorin-7/28/2011
4661Entrepreneurship Published online: 21 July 2011, doi:10.1038/bioe.2011.7 The Isibob zagorin-7/27/2011
4660Piper Jaffray Updates On ISIS Following Shareholders Meeting By BenzingaStaffT Bbob zagorin-6/20/2011
4659repost from IV "...JEFFRIES WEBCAST I just listened to Lynn's presentabob zagorin-6/10/2011
4658Isis Pharmaceuticals announces publication of new data concerning microRNA-33 Rebob zagorin-6/7/2011
4657>> Box 1 | The many faces of antisense therapy FROM THE FOLLOWING ARTICLEbob zagorin-6/2/2011
4656The long march of antisense >> Nature Reviews Drug Discovery 10, 401-402 bob zagorin-6/2/2011
4654Isis Initiates Phase 1 Study of ISIS-TTRRx and Earns $5 Million Milestone Paymenbob zagorin-5/19/2011
4653$3 Million Here, $1.5 Billion There By Brian Orelli | More Articles (Motley Foobob zagorin-5/18/2011
4652Isis Earns $3 Million Payment as Collaboration With GSK Expands Press Release Sobob zagorin-5/16/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):